IPSEN (IPN.PA) Stock Fundamental Analysis

EPA:IPN • FR0010259150

165.1 EUR
+4.6 (+2.87%)
Last: Feb 27, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Fundamental Rating

6

Taking everything into account, IPN scores 6 out of 10 in our fundamental rating. IPN was compared to 52 industry peers in the Pharmaceuticals industry. IPN is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. IPN has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

  • IPN had positive earnings in the past year.
  • IPN had a positive operating cash flow in the past year.
  • IPN had positive earnings in each of the past 5 years.
  • In the past 5 years IPN always reported a positive cash flow from operatings.
IPN.PA Yearly Net Income VS EBIT VS OCF VS FCFIPN.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M 800M 1B

1.2 Ratios

  • With a decent Return On Assets value of 11.21%, IPN is doing good in the industry, outperforming 78.85% of the companies in the same industry.
  • Looking at the Return On Equity, with a value of 17.93%, IPN is in the better half of the industry, outperforming 61.54% of the companies in the same industry.
  • With an excellent Return On Invested Capital value of 21.54%, IPN belongs to the best of the industry, outperforming 88.46% of the companies in the same industry.
Industry RankSector Rank
ROA 11.21%
ROE 17.93%
ROIC 21.54%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
IPN.PA Yearly ROA, ROE, ROICIPN.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5 10 15 20 25

1.3 Margins

  • The Profit Margin of IPN (13.25%) is comparable to the rest of the industry.
  • In the last couple of years the Profit Margin of IPN has declined.
  • IPN has a Operating Margin of 25.32%. This is in the better half of the industry: IPN outperforms 61.54% of its industry peers.
  • IPN's Operating Margin has been stable in the last couple of years.
  • The Gross Margin of IPN (81.66%) is better than 86.54% of its industry peers.
  • In the last couple of years the Gross Margin of IPN has remained more or less at the same level.
Industry RankSector Rank
OM 25.32%
PM (TTM) 13.25%
GM 81.66%
OM growth 3Y-3.38%
OM growth 5Y-1.48%
PM growth 3Y-18.1%
PM growth 5Y-11.16%
GM growth 3Y-0.97%
GM growth 5Y-0.21%
IPN.PA Yearly Profit, Operating, Gross MarginsIPN.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40 60 80

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so IPN is creating value.
  • There is no outstanding debt for IPN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
IPN.PA Yearly Shares OutstandingIPN.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
IPN.PA Yearly Total Debt VS Total AssetsIPN.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

  • IPN has an Altman-Z score of 4.98. This indicates that IPN is financially healthy and has little risk of bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 4.98, IPN is in the better half of the industry, outperforming 73.08% of the companies in the same industry.
  • The Debt to FCF ratio of IPN is 1.18, which is an excellent value as it means it would take IPN, only 1.18 years of fcf income to pay off all of its debts.
  • IPN has a better Debt to FCF ratio (1.18) than 90.38% of its industry peers.
  • A Debt/Equity ratio of 0.19 indicates that IPN is not too dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.19, IPN is in the better half of the industry, outperforming 73.08% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.19
Debt/FCF 1.18
Altman-Z 4.98
ROIC/WACC2.66
WACC8.11%
IPN.PA Yearly LT Debt VS Equity VS FCFIPN.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B 2B 3B 4B

2.3 Liquidity

  • A Current Ratio of 1.96 indicates that IPN should not have too much problems paying its short term obligations.
  • IPN has a better Current ratio (1.96) than 71.15% of its industry peers.
  • A Quick Ratio of 1.79 indicates that IPN should not have too much problems paying its short term obligations.
  • The Quick ratio of IPN (1.79) is better than 82.69% of its industry peers.
Industry RankSector Rank
Current Ratio 1.96
Quick Ratio 1.79
IPN.PA Yearly Current Assets VS Current LiabilitesIPN.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. Growth

3.1 Past

  • IPN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 12.24%, which is quite good.
  • Measured over the past years, IPN shows a quite strong growth in Earnings Per Share. The EPS has been growing by 8.79% on average per year.
  • The Revenue has grown by 64.12% in the past year. This is a very strong growth!
  • The Revenue has been growing slightly by 5.83% on average over the past years.
EPS 1Y (TTM)12.24%
EPS 3Y4.15%
EPS 5Y8.79%
EPS Q2Q%9.65%
Revenue 1Y (TTM)64.12%
Revenue growth 3Y9.15%
Revenue growth 5Y5.83%
Sales Q2Q%1.83%

3.2 Future

  • Based on estimates for the next years, IPN will show a small growth in Earnings Per Share. The EPS will grow by 5.28% on average per year.
  • IPN is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.49% yearly.
EPS Next Y10.38%
EPS Next 2Y5.39%
EPS Next 3Y4.79%
EPS Next 5Y5.28%
Revenue Next Year8.75%
Revenue Next 2Y7.59%
Revenue Next 3Y6.8%
Revenue Next 5Y4.49%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
IPN.PA Yearly Revenue VS EstimatesIPN.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 1B 2B 3B 4B
IPN.PA Yearly EPS VS EstimatesIPN.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2 4 6 8 10

More info and screens

Find the best growth stocksShow best growing peers

5

4. Valuation

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 16.08, the valuation of IPN can be described as correct.
  • 67.31% of the companies in the same industry are more expensive than IPN, based on the Price/Earnings ratio.
  • The average S&P500 Price/Earnings ratio is at 27.10. IPN is valued slightly cheaper when compared to this.
  • IPN is valuated correctly with a Price/Forward Earnings ratio of 14.47.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of IPN indicates a somewhat cheap valuation: IPN is cheaper than 75.00% of the companies listed in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 28.06, IPN is valued a bit cheaper.
Industry RankSector Rank
PE 16.08
Fwd PE 14.47
IPN.PA Price Earnings VS Forward Price EarningsIPN.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of IPN indicates a rather cheap valuation: IPN is cheaper than 94.23% of the companies listed in the same industry.
  • IPN's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. IPN is cheaper than 75.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 16.71
EV/EBITDA 6.1
IPN.PA Per share dataIPN.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

  • IPN's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • IPN has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)1.55
PEG (5Y)1.83
EPS Next 2Y5.39%
EPS Next 3Y4.79%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

4

5. Dividend

5.1 Amount

  • IPN has a yearly dividend return of 0.88%, which is pretty low.
  • IPN's Dividend Yield is comparable with the industry average which is at 1.89.
  • With a Dividend Yield of 0.88, IPN pays less dividend than the S&P500 average, which is at 1.80.
Industry RankSector Rank
Dividend Yield 0.88%

5.2 History

  • The dividend of IPN has a limited annual growth rate of 3.72%.
Dividend Growth(5Y)3.72%
Div Incr Years1
Div Non Decr Years4
IPN.PA Yearly Dividends per shareIPN.PA Yearly Dividends per shareYearly Dividends per share 2018 2019 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8 1

5.3 Sustainability

  • IPN pays out 14.95% of its income as dividend. This is a sustainable payout ratio.
  • IPN's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP14.95%
EPS Next 2Y5.39%
EPS Next 3Y4.79%
IPN.PA Yearly Income VS Free CF VS DividendIPN.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M 800M
IPN.PA Dividend Payout.IPN.PA Dividend Payout, showing the Payout Ratio.IPN.PA Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

IPSEN

EPA:IPN (2/27/2026, 7:00:00 PM)

165.1

+4.6 (+2.87%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)02-12
Earnings (Next)07-29
Inst Owners15.35%
Inst Owner ChangeN/A
Ins Owners0.27%
Ins Owner ChangeN/A
Market Cap13.84B
Revenue(TTM)5.87B
Net Income(TTM)777.50M
Analysts69.47
Price Target135.82 (-17.73%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.88%
Yearly Dividend1.2
Dividend Growth(5Y)3.72%
DP14.95%
Div Incr Years1
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)3.65%
PT rev (3m)2.37%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)3.07%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)2.57%
Revenue NY rev (3m)2.82%
Valuation
Industry RankSector Rank
PE 16.08
Fwd PE 14.47
P/S 2.36
P/FCF 16.71
P/OCF 11.96
P/B 3.19
P/tB 9.79
EV/EBITDA 6.1
EPS(TTM)10.27
EY6.22%
EPS(NY)11.41
Fwd EY6.91%
FCF(TTM)9.88
FCFY5.98%
OCF(TTM)13.8
OCFY8.36%
SpS70
BVpS51.74
TBVpS16.87
PEG (NY)1.55
PEG (5Y)1.83
Graham Number109.34
Profitability
Industry RankSector Rank
ROA 11.21%
ROE 17.93%
ROCE 27.02%
ROIC 21.54%
ROICexc 29.88%
ROICexgc 113.42%
OM 25.32%
PM (TTM) 13.25%
GM 81.66%
FCFM 14.11%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-3.38%
OM growth 5Y-1.48%
PM growth 3Y-18.1%
PM growth 5Y-11.16%
GM growth 3Y-0.97%
GM growth 5Y-0.21%
F-Score7
Asset Turnover0.85
Health
Industry RankSector Rank
Debt/Equity 0.19
Debt/FCF 1.18
Debt/EBITDA 0.4
Cap/Depr 52.58%
Cap/Sales 5.6%
Interest Coverage 250
Cash Conversion 54.79%
Profit Quality 106.48%
Current Ratio 1.96
Quick Ratio 1.79
Altman-Z 4.98
F-Score7
WACC8.11%
ROIC/WACC2.66
Cap/Depr(3y)123.84%
Cap/Depr(5y)123.25%
Cap/Sales(3y)11.93%
Cap/Sales(5y)11.8%
Profit Quality(3y)111.08%
Profit Quality(5y)104.31%
High Growth Momentum
Growth
EPS 1Y (TTM)12.24%
EPS 3Y4.15%
EPS 5Y8.79%
EPS Q2Q%9.65%
EPS Next Y10.38%
EPS Next 2Y5.39%
EPS Next 3Y4.79%
EPS Next 5Y5.28%
Revenue 1Y (TTM)64.12%
Revenue growth 3Y9.15%
Revenue growth 5Y5.83%
Sales Q2Q%1.83%
Revenue Next Year8.75%
Revenue Next 2Y7.59%
Revenue Next 3Y6.8%
Revenue Next 5Y4.49%
EBIT growth 1Y87.65%
EBIT growth 3Y3.94%
EBIT growth 5Y6.31%
EBIT Next Year24.19%
EBIT Next 3Y10.15%
EBIT Next 5Y4.57%
FCF growth 1Y522.48%
FCF growth 3Y4.75%
FCF growth 5Y5.6%
OCF growth 1Y26.34%
OCF growth 3Y5.92%
OCF growth 5Y8.44%

IPSEN / IPN.PA FAQ

What is the fundamental rating for IPN stock?

ChartMill assigns a fundamental rating of 6 / 10 to IPN.PA.


What is the valuation status of IPSEN (IPN.PA) stock?

ChartMill assigns a valuation rating of 5 / 10 to IPSEN (IPN.PA). This can be considered as Fairly Valued.


Can you provide the profitability details for IPSEN?

IPSEN (IPN.PA) has a profitability rating of 6 / 10.


What is the financial health of IPSEN (IPN.PA) stock?

The financial health rating of IPSEN (IPN.PA) is 7 / 10.


How sustainable is the dividend of IPSEN (IPN.PA) stock?

The dividend rating of IPSEN (IPN.PA) is 4 / 10 and the dividend payout ratio is 14.95%.